Akèy › Maladi selil fòs › Kalifòni › Orange
Etid klinik pou Maladi selil fòs nan Orange, CA
3 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Ctr for Inherited Blood Disorders, Orange
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Ap rekriteFaz 2
- University of California Irvine, Orange
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Ap rekriteFaz 2
- University of California Irvine, Orange
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Washington, DC20 etid
- Memphis, TN18 etid
- Chicago, IL18 etid
- Philadelphia, PA15 etid
- Birmingham, AL14 etid
- New York City, NY13 etid
- St. Louis, MO12 etid
- Durham, NC10 etid
- Cincinnati, OH10 etid
- Boston, MA10 etid
- Houston, TX10 etid
Lòt etid nan Orange
- Kansè Poumon ki pa ti selil25 etid
- Kansè Metastatik20 etid
- Kansè kolorektal16 etid
- Kansè ovè16 etid
- Kansè pankreyas15 etid
- Kansè nan tete14 etid
- Kansè poumon14 etid
- Kansè pwostat14 etid
- Kansè fwa (Kasinòm epatoselilè)14 etid
- Melanom14 etid
- Leksemi mieloïd egi13 etid
- Kansè (tout kalite)13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.